Formulation Optimization and In Vitro Evaluation of a β-Blocker Sustained-Release Delivery System for Enhanced Drug Delivery and Therapeutic Outcomes

Q: How many days will it take for my paper to be published?

The review time for papers is not fixed. However, if the paper is accepted and the author completes the processing charges formalities, the paper will be published within a few working days.

Q: I would like to receive a hard copy of the journal materials. Are there any additional charges?

You can log in to the author portal and pay 500 INR to receive the hard copy materials.

Q: Do IJIRT provide DOI for published papers?

Yes, we provide a DOI (Digital Object Identifier) upon request. Authors can contact us at editor@ijirt.org after publication to obtain the DOI for their paper.

Q: Do we provide Published Journal Print copy?

No, we do not provide Published Journal Print copy.

Q: Why am I not able to register to IPN?

There might be three potential reasons: 1) You did not verify your mobile number before clicking on the register button. Please click on the Verify sign immediately after entering your mobile number and complete OTP verification. 2) You are an international author. The IPN is enabled only for Indian Authors. 3) You did not tick the Terms & Conditions checkbox. Please make sure to select it before clicking on the register button.

Q: Where can I get a sample publication certificate?

Please login to Author Home, where you will find the sample copy of the publication certificate and confirmation letter.

Q: I made the processing charges payment and the amount is deducted from my bank account, but it is not updated in my Author Home. What should I do?

Please wait for one working day. We will check at our end and update the status. If it is still not updated after one working day, please email your Razorpay Payment ID along with the payment proof snapshot to editor@ijirt.org.

Q: Where can I sign the Copyright and Undertaking Declaration?

To publish your paper in IJIRT, copyright and undertaking is mandatory. You can digitally sign both by logging into Author Home and checking the right-side section.

Q: How many pages are allowed?

There is no page limit. However, to enhance quality and reader experience, we recommend keeping the paper up to 30 pages (single or double column) without extra charges.

Q: How many authors per paper are allowed?

Up to 13 authors are allowed without extra charges.

K Stephen Daniel

Formulation Optimization and In Vitro Evaluation of a β-Blocker Sustained-Release Delivery System for Enhanced Drug Delivery and Therapeutic Outcomes

Authors: K Stephen Daniel

Unique Paper ID: 204670
Volume: 13
Issue: 1
PageNo: 3487-3491

Keywords: No Keywords Found

Abstract:
No Abstract Found

Download article

email to a friend

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{204670,
        author = {K Stephen Daniel},
        title = {Formulation Optimization and In Vitro Evaluation of a β-Blocker Sustained-Release Delivery System for Enhanced Drug Delivery and Therapeutic Outcomes},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {13},
        number = {1},
        pages = {3487-3491},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=204670},
        abstract = {},
        keywords = {},
        month = {June},
        }

Download .bib

Cite This Article

Daniel, K. S. (2026). Formulation Optimization and In Vitro Evaluation of a β-Blocker Sustained-Release Delivery System for Enhanced Drug Delivery and Therapeutic Outcomes. International Journal of Innovative Research in Technology (IJIRT), 13(1), 3487–3491.

09 Jun, 2026

Global Regulatory Perspectives on Manufacturing Practices, Quality Assurance and Approval Processes of Herbal Pharmaceutical Products

06 Jun, 2026

Analytical Method Development and Validation for Estimation of Cardio Protective Agents in Formulated Dosage Form By RP-HPLC Method

06 Jun, 2026

Development and Validation of A Stability-Indicating RP-HPLC Method For The Simultaneous Estimation of Eprosartan and Hydrochlorothiazide in Bulk and Pharmaceutical Dosage Forms

06 Jun, 2026

Analytical Method Development and Validation of Combined Anti-Hypertensive Agents in Bulk And Dosage Forms Using RP-HPLC According To ICH Guidelines

06 Jun, 2026

RP-HPLC-Based Quantitative Analysis of Multi-Component Antineoplastic Dosage Forms: Method Development and Validation

06 Jun, 2026

Stability Indicating RP-HPLC Method for The Simultaneous Estimation of L-Methyl Folate and Escitalopram in Bulk and Pharmaceutical Dosage Form

05 Jun, 2026

Regulatory Compliance in The Pharmaceutical Sector: Its Role, Challenges, And Impact On Industrial Development And Product Safety

05 Jun, 2026

Global Standardization of Pharmaceutical Regulations: Bridging Regulatory Gaps Across International Markets

05 Jun, 2026

Trade-Related Aspects of Intellectual Property Rights And Regulatory Auditing: Current Trends And Challenges in D-8 Countries

05 Jun, 2026

Comparative Analysis of Medical Device Regulations And Approval Pathways in the United States, European Union, And India

Impact Factor
8.412 (Year 2026)

An UGC-Compliant International Research Journal

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now